AAAAAA
Results:
1-14
|
Results: 14
Authors:
CHAO AC
TAYLOR MT
DADDONA PE
BROUGHALL M
FIX JA
Citation: Ac. Chao et al., MOLECULAR WEIGHT-DEPENDENT PARACELLULAR TRANSPORT OF FLUORESCENT MODEL COMPOUNDS INDUCED BY PALMITOYLCARNITINE CHLORIDE ACROSS THE HUMAN INTESTINAL EPITHELIAL-CELL LINE CACO-2, Journal of drug targeting, 6(1), 1998, pp. 37-43
Authors:
FOREMAN PK
WAINWRIGHT MJ
ALICKE B
KOVESDI I
WICKHAM TJ
SMITH JG
MEIERDAVIS S
FIX JA
DADDONA P
GARDNER P
HUANG MTF
Citation: Pk. Foreman et al., ADENOVIRUS-MEDIATED TRANSDUCTION OF INTESTINAL-CELLS IN-VIVO, Human gene therapy, 9(9), 1998, pp. 1313-1321
Authors:
CHAO AC
NGUYEN JV
BROUGHALL M
RECCHIA J
KENSIL CR
DADDONA PE
FIX JA
Citation: Ac. Chao et al., ENHANCEMENT OF INTESTINAL MODEL-COMPOUND TRANSPORT BY DS-1, A MODIFIED QUILLAJA SAPONIN, Journal of pharmaceutical sciences, 87(11), 1998, pp. 1395-1399
Authors:
TAYLOR MT
BROUGHALL M
CHAO AC
FIX JA
Citation: Mt. Taylor et al., MOLECULAR WEIGHT-DEPENDENT TRANSPORT OF HYDROPHILIC MODEL COMPOUNDS ACROSS CACO-2 COLONIC EPITHELIAL-CELLS IN THE PRESENCE OF PALMITOYLCARNITINE CHLORIDE (PCC), The FASEB journal, 10(3), 1996, pp. 696-696
Authors:
FIX JA
Citation: Ja. Fix, ORAL CONTROLLED-RELEASE TECHNOLOGY FOR PEPTIDES - STATUS AND FUTURE-PROSPECTS, Pharmaceutical research, 13(12), 1996, pp. 1760-1764
Authors:
FIX JA
Citation: Ja. Fix, STRATEGIES FOR DELIVERY OF PEPTIDES UTILIZING ABSORPTION-ENHANCING AGENTS, Journal of pharmaceutical sciences, 85(12), 1996, pp. 1282-1285
Authors:
WOOD RC
LECLUYSE EL
FIX JA
Citation: Rc. Wood et al., ASSESSMENT OF A MODEL FOR MEASURING DRUG DIFFUSION THROUGH IMPLANT-GENERATED FIBROUS CAPSULE MEMBRANES, Biomaterials, 16(12), 1995, pp. 957-959
Authors:
HOCHMAN JH
FIX JA
LECLUYSE EL
Citation: Jh. Hochman et al., IN-VITRO AND IN-VIVO ANALYSIS OF THE MECHANISM OF ABSORPTION ENHANCEMENT BY PALMITOYLCARNITINE, The Journal of pharmacology and experimental therapeutics, 269(2), 1994, pp. 813-822
Authors:
LEPPERT PS
FIX JA
Citation: Ps. Leppert et Ja. Fix, USE OF EVERTED INTESTINAL RINGS FOR IN-VITRO EXAMINATION OF ORAL ABSORPTION POTENTIAL, Journal of pharmaceutical sciences, 83(7), 1994, pp. 976-981
Authors:
LEPPERT PS
CAMMACK L
CARGILL R
COFFMAN L
CORTESE M
ENGLE K
KRUPCO C
FIX JA
Citation: Ps. Leppert et al., INTERSPECIES DIFFERENCES IN SYSTEMIC DRUG AVAILABILITY FOLLOWING SUBCUTANEOUS PULSATILE ADMINISTRATION IN CATTLE, SHEEP, DOGS, AND RATS, Journal of biomedical materials research, 28(6), 1994, pp. 713-722
Authors:
FIX JA
CARGILL R
ENGLE K
Citation: Ja. Fix et al., CONTROLLED GASTRIC-EMPTYING .3. GASTRIC RESIDENCE TIME OF A NONDISINTEGRATING GEOMETRIC SHAPE IN HUMAN VOLUNTEERS, Pharmaceutical research, 10(7), 1993, pp. 1087-1089
Authors:
SUTTON SC
ENGLE K
FIX JA
Citation: Sc. Sutton et al., INTRANASAL DELIVERY OF THE BISPHOSPHONATE ALENDRONATE IN THE RAT AND DOG, Pharmaceutical research, 10(6), 1993, pp. 924-926
Authors:
SUTTON SC
LECLUYSE EL
ENGLE K
PIPKIN JD
FIX JA
Citation: Sc. Sutton et al., ENHANCED BIOAVAILABILITY OF CEFOXITIN USING PALMITOYLCARNITINE .2. USE OF DIRECTLY COMPRESSED TABLET FORMULATIONS IN THE RAT AND DOG, Pharmaceutical research, 10(10), 1993, pp. 1516-1520
Authors:
LECLUYSE EL
SUTTON SC
FIX JA
Citation: El. Lecluyse et al., INVITRO EFFECTS OF LONG-CHAIN ACYLCARNITINES ON THE PERMEABILITY, TRANSEPITHELIAL ELECTRICAL-RESISTANCE AND MORPHOLOGY OF RAT COLONIC MUCOSA, The Journal of pharmacology and experimental therapeutics, 265(2), 1993, pp. 955-962
Risultati:
1-14
|